Figure 5
From: Decreased miR-106a inhibits glioma cell glucose uptake and proliferation by targeting SLC2A3 in GBM
MiR-106a inhibits glioma cell glucose uptake in vitro. (A) In silico analysis of SLC2A3 mRNA expression and the correlation to apoptosis-related mRNAs. Heatmap of gene expression of glycolysis-related genes in patients was sorted by level of SLC2A3 expression (columns). (B and C) After 48Â h treatment of miR-106a or SLC2A3 siRNA, cells were harvested and glucose uptake and intracellular ATP production assays were performed. Data were presented as the mean of triplicate experiments.